PHILIP GURECKI: Open Payments
NPI 1811370869 · NEWPORT NEWS, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,489 in 144 payments from 35 companies in 2025. Trend: 2023 $2,824 · 2024 $2,467 · 2025 $2,489
Food & beverage: $2,489
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 18 | $330 |
| PFIZER INC. | 21 | $279 |
| ABBVIE INC. | 13 | $168 |
| GlaxoSmithKline, LLC. | 8 | $159 |
| Amgen Inc. | 14 | $149 |
| Lilly USA, LLC | 8 | $142 |
| Otsuka America Pharmaceutical, Inc. | 6 | $120 |
| Novartis Pharmaceuticals Corporation | 6 | $115 |
| AstraZeneca Pharmaceuticals LP | 6 | $90 |
| Novo Nordisk Inc | 4 | $83 |
Products named: Sunosi, ELIQUIS, TRELEGY ELLIPTA, NURTEC ODT, Auvelity, REXULTI, LEQVIO, OTEZLA.
Industry payments across VA — which companies pay providers there.
